The Professional Society for Health Economics and Outcomes Research (ISPOR) is a global non-profit organisation. It promotes the use of health economics and outcomes research (HEOR) in medical care decision-making. Recently, CEO Rob Abbott discussed the organisation’s objective, the importance of HEOR, and the future of healthcare.
ISPOR’s membership is comprised of individuals from academia, industry, patient groups, and payers. These individuals come from 110 different countries. This organisation’s work would not be possible without its broad membership. This guides debates and conversations by offering a variety of perspectives.
Abbott stressed the crucial role of HEOR in today’s world, particularly in overburdened healthcare systems. HEOR offers valuable data and insights, aiding tough decisions in the healthcare sector. It helps achieve superior results at lower costs.
In addition, Abbott clarified the differences between HEOR and health technology assessment (HTA). Compared to HEOR, which includes a wider field of research and incorporates notions such as real-world evidence, real-world data, and patient participation, HTA primarily concentrates on the effectiveness of a particular technology.
The CEO also discussed the potential and difficulties that will exist in the healthcare industry in the year 2030. Some of these problems and opportunities include the concept of whole health, as well as affordability and sustainability. He stressed the significance of scientific rigor and evidence in the process of guiding decisions and policies pertaining to healthcare.
The function of ISPOR in developing markets was on the table. These markets are experiencing an acute shortage of practicable health economic models. ISPOR has regional chapters in over one hundred countries. The majority of which are either economies in transition or countries with low or middle incomes. The organisation is providing substantial assistance in the form of active support for the development of HEOR capacity and its use in these regions.
Lastly, Abbott discussed the significance of incorporating the viewpoints and preferences of patients into the decision-making processes that take place inside the healthcare system. ISPOR has long been dedicated to achieving this objective. In order to ensure that the patient voice is heard, the organisation has formed patient roundtables and a special interest group.
Abbott concluded his speech by emphasising ISPOR’s dedication to incorporating HEOR into decision-making. Their goal is to improve health outcomes at a more affordable cost. He invited anyone interested in HEOR or enhancing the accessibility, equity, and impact of healthcare systems on patients, to join ISPOR.
💊 Could MFN Pricing Undermine Biosimilars?
MFN drug pricing aims to cut costs—but its indirect pressure on biosimilars may reduce competition (create a void) and raise long-term prices.
Explore the risks and what stakeholders can do to protect market sustainability.
#SyenzaNews #Biosimilars #DrugPricing #HealthPolicy #Pharma #MarketAccess
🔍 Are you prepared for the upcoming EU AI Act in healthcare?
As the first comprehensive AI regulation globally rolls out, healthcare organizations must move beyond mere compliance. The urgency lies in embedding ethical, trusted, and sustainable AI practices into every facet of healthcare AI. Early adoption of ethical assessments and collaboration is essential to navigate the complex regulatory landscape before the August 2026 deadline.
Learn about proactive compliance strategies that not only meet regulatory standards but also enhance patient trust and system efficacy!
#SyenzaNews #AIinHealthcare #HealthcareInnovation #DigitalTransformation
💉 Are we doing enough to bridge the gap in hepatitis vaccine uptake?
A recent article highlights that while over 90% of children are vaccinated against hepatitis B, adult rates are alarmingly low, posing a significant public health risk. Jeff Goad from the National Foundation for Infectious Diseases emphasizes the crucial role pharmacists can play in increasing access and dispelling common misconceptions about vaccines.
Join the conversation on enhancing vaccination strategies for better health outcomes!
#SyenzaNews #Healthcare #HealthEconomics
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
